L3VLUP
ProSign in

CVS in the 13F filings

CVS Health Corp · CUSIP 126650100

Sector · Consumer staples
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Mar 2024
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 3 May 2024
Managers listing it
21
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q4 2023 and Q1 2024; 19 listed it in both
Shares listed
179,104,160
combined, among listed positions
Reported value
$14.3bn
combined, at the quarter end

Among the 93 comparable managers: 9 buyers (opened or added shares) and 14 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing CVS in Q1 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

21 of 21 holders

ActionFiling
Capital World Investors43,776,874$3.5bn0.58%Added+3,232,17214 May 2024 (the filing on sec.gov)
Dodge & Cox41,012,543$3.3bn1.90%Added+10,599,15314 May 2024 (the filing on sec.gov)
Fidelity (FMR LLC)34,423,281$2.7bn0.18%Trimmed-3,395,5035 Nov 2026 (the filing on sec.gov)
Invesco Ltd14,636,775$1.2bn0.25%Trimmed-1,323,28314 May 2024 (the filing on sec.gov)
Capital Research Global Investors13,143,822$1.0bn0.24%Added+184,29714 May 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc10,699,034$853m0.10%Added+13,26815 May 2024 (the filing on sec.gov)
Harris Associates LP4,325,860$345m0.56%Added+165,20815 May 2024 (the filing on sec.gov)
AQR Capital Management LLC3,961,933$315m0.54%Trimmed-448,71815 May 2024 (the filing on sec.gov)
Neuberger Berman Group LLC2,674,862$213m0.18%Trimmed-16,32114 Nov 2024 (the filing on sec.gov)
Bridgewater Associates LP2,454,617$196m0.99%Trimmed-599,78714 May 2024 (the filing on sec.gov)
Glenview Capital Management LLC1,696,430$135m2.37%Added+950,28615 May 2024 (the filing on sec.gov)
Marshall Wace LLP1,677,908$134m0.20%Trimmed-3,168,51315 May 2024 (the filing on sec.gov)
AllianceBernstein LP1,604,494$128munder 0.1%Trimmed-125,67114 May 2024 (the filing on sec.gov)
Balyasny Asset Management LLC829,138$66m0.12%Addedn.a.13 May 2024 (the filing on sec.gov)
Arrowstreet Capital LP635,118$51munder 0.1%Newnew15 May 2024 (the filing on sec.gov)
Voloridge Investment Management LLC627,747$50m0.18%Added+240,09615 May 2024 (the filing on sec.gov)
Markel Group Inc332,000$26m0.26%Held03 May 2024 (the filing on sec.gov)
Acadian Asset Management LLC246,905$20m0.07%Trimmed-5,37210 May 2024 (the filing on sec.gov)
GAMCO Investors Inc186,514$15m0.15%Trimmed-21,39014 May 2024 (the filing on sec.gov)
Verition Fund Management LLC134,651$11m0.07%Trimmed-81,28214 May 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP23,654$1.9munder 0.1%Trimmed-15015 May 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2023 to Q1 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (3)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
31 in Q3 2024 to 31 in Q2 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CVS by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201319$12.0bnn.a.n.a.
Q3 201322$11.8bnn.a.n.a.
Q4 201319$14.0bnn.a.n.a.
Q1 201417$15.3bnn.a.n.a.
Q2 201424$14.7bnn.a.n.a.
Q3 201421$15.4bnn.a.n.a.
Q4 201424$18.3bnn.a.n.a.
Q1 201525$19.7bnn.a.n.a.
Q2 201524$20.2bnn.a.n.a.
Q3 201530$19.0bnn.a.n.a.
Q4 201525$17.8bnn.a.n.a.
Q1 201624$17.1bnn.a.n.a.
Q2 201634$14.3bnn.a.n.a.
Q3 201630$12.8bnn.a.n.a.
Q4 201632$9.3bnn.a.n.a.
Q1 201729$8.7bnn.a.n.a.
Q2 201720$9.0bnn.a.n.a.
Q3 201723$9.4bnn.a.n.a.
Q4 201732$10.5bnn.a.n.a.
Q1 201831$8.7bnn.a.n.a.
Q2 201821$8.1bnn.a.n.a.
Q3 201825$10.7bnn.a.n.a.
Q4 201833$11.4bnn.a.n.a.
Q1 201927$8.5bnn.a.n.a.
Q2 201925$8.0bnn.a.n.a.
Q3 201925$9.6bnn.a.n.a.
Q4 201927$11.4bnn.a.n.a.
Q1 202029$8.1bnn.a.n.a.
Q2 202026$9.3bnn.a.n.a.
Q3 202029$8.9bnn.a.n.a.
Q4 202022$9.8bnn.a.n.a.
Q1 202128$10.3bnn.a.n.a.
Q2 202124$11.8bnn.a.n.a.
Q3 202128$11.9bnn.a.n.a.
Q4 202128$14.7bnn.a.n.a.
Q1 202225$14.4bnn.a.n.a.
Q2 202230$13.5bnn.a.n.a.
Q3 202228$13.9bnn.a.n.a.
Q4 202230$12.6bnn.a.n.a.
Q1 202336$9.6bnn.a.n.a.
Q2 202333$9.8bnn.a.n.a.
Q3 202333$11.7bnn.a.n.a.
Q4 202332$14.2bn1518
Q1 202421$14.3bn914
Q2 202424$14.2bn168
Q3 202431$14.2bn2310
Q4 202432$11.0bn1716
Q1 202529$19.1bn2010
Q2 202531$19.6bn1912
Q3 202528$21.9bn1611
Q4 202529$22.8bn1823
Q1 202632$21.1bn2420
Q2 202631$30.8bn1824

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CVS and PM →CVS and KO →CVS and COST →Choose a stock to compare with CVS →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CVS, latest filings →Back to the 13F Explorer →